Stockscreener 앱 받기
4.63
7.58%
-0.38
Scpharmaceuticals Inc 주식(SCPH)의 최신 뉴스
Wall Street Zen Upgrades scPharmaceuticals (NASDAQ:SCPH) to “Hold” - Defense World
Using R and stats models for scPharmaceuticals Inc. forecastingFree High Return Stock Focus With Safety - Newser
Strategies to average down on scPharmaceuticals Inc.Multi-Bagger Detection with Trend Tools - Newser
How scPharmaceuticals Inc. stock performs during market volatilitySafe Entry Strategy with High Win Rate - Newser
scPharmaceuticals Inc. stock trendline breakdownDaily Technical Chart Pattern Analysis Report - Newser
What makes scPharmaceuticals Inc. stock price move sharplyTop Stock Picks with Forecast Accuracy - Newser
Analyzing scPharmaceuticals Inc. with multi timeframe chartsWealth Accumulation Outlook for Safe Investors - Newser
Identifying reversal signals in scPharmaceuticals Inc.Long Term Stock Growth Plan Suggestions - Newser
Is scPharmaceuticals Inc. forming a reversal patternSector Rotation Strategy for Smart Traders - Newser
Analyzing net buyer seller activity in scPharmaceuticals Inc.AI-Powered Stock Trend Movement Analysis - Newser
scPharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Fast Entry High Potential Stock Alerts - Newser
Building trade automation scripts for scPharmaceuticals Inc.Watchlist Summary for Active Day Traders - Newser
Chart based analysis of scPharmaceuticals Inc. trendsLoss Limitation Strategy Based on Analysis - Newser
ScPharmaceuticals anticipates meaningful Q3 nephrology contribution as FUROSCIX shipments rise 45% in Q2 2025 - MSN
Strong Financial Performance and Strategic Initiatives Justify Buy Rating for scPharmaceuticals - TipRanks
Can a trend reversal in scPharmaceuticals Inc. lead to recoveryTechnical Setup and Return Forecast Engine - Newser
What Fibonacci levels say about scPharmaceuticals Inc. reboundWatchlist Generator With Real-Time Entry - Newser
Sentiment analysis tools applied to scPharmaceuticals Inc.Investment Position Summary with Timeframe Forecast - Newser
Is scPharmaceuticals Inc. stock bottoming outFree Real Market Momentum Signal Generator - Newser
How to monitor scPharmaceuticals Inc. with trend dashboardsFree AI Powered High Return Stock Calls - Newser
Scpharmaceuticals 2025 Q2 Earnings Loss Narrows Despite Revenue Surge - AInvest
Using data tools to time your scPharmaceuticals Inc. exitTechnical Long-Term Outlook and Recap Guide - Newser
SCPH Revenue Up 99% - AOL.com
scPharmaceuticals Reports Strong Q2 2025 Growth - TipRanks
scPharmaceuticals Inc (SCPH) Q2 2025 Earnings Call Highlights: R - GuruFocus
scPharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Promising Outlook for scPharmaceuticals: Buy Rating Supported by Strong Furoscix Demand and Strategic Growth Initiatives - TipRanks
scPharmaceuticals reports Q2 EPS (34c), consensus (30c) - TipRanks
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Scpharmaceuticals earnings missed by $0.05, revenue topped estimates - Investing.com Australia
Momentum divergence signals in scPharmaceuticals Inc. chartFree Weekly Potential Breakout Stock List - Newser
Using Bollinger Bands to evaluate scPharmaceuticals Inc.Smart Swing Picks with Confirmed Signals - Newser
What institutional flow reveals about scPharmaceuticals Inc.Weekly Movement Forecast With Chart Signals - Newser
Shareholders in scPharmaceuticals (NASDAQ:SCPH) are in the red if they invested five years ago - Yahoo Finance
What’s the recovery path for long term holders of scPharmaceuticals Inc.Strategy Chart for Real-Time Trade Flow - Newser
Will scPharmaceuticals Inc. rebound enough to break evenFree Long Hold Safe Return Strategy - Newser
Is It Too Early to Call Recovery in scPharmaceuticals Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it
Should you wait for a breakout in scPharmaceuticals Inc.Free Buy Low Sell High Stock Watch - Newser
Is scPharmaceuticals Inc. a candidate for recovery playFree Buy Alerts With Low Risk Confirmation - Newser
Why is scPharmaceuticals Inc. stock attracting strong analyst attentionFree Investment Timing Strategies - Jammu Links News
scPharmaceuticals Inc. Stock Analysis and ForecastNavigate the market with precision tools - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):